HOME >> MEDICINE >> NEWS
EDCTP welcomes G8 support for HIV/AIDS vaccine development

The Hague, the Netherlands On 10th June 2004 during this year's summit in Sea Island, Georgia, the G8 Leaders called for the establishment of a Global HIV Vaccine Enterprise: a virtual consortium to accelerate HIV vaccine development by enhancing coordination, information sharing, and global collaboration. The EDCTP is pleased to see this expression of support and commitment to accelerating the research on and availability of a vaccine against HIV, one of the major impediments today to sustainable development of underprivileged countries.

The European and Developing Countries Clinical Trials Partnership (EDCTP) believes that critical impediments to development such as the ones inflicted by HIV/AIDS, must be addressed by having the Developing Countries benefit from both the tools resulting from research (based on their public health needs), and the systems which they have acquired to assess those tools independently.

The renewed emphasis about HIV expressed by the G8 Leaders is welcome, timely and only too needed. At the same time, we must not forget that the same challenges are being faced with tuberculosis and malaria, as well as other, more neglected causes of illness and poverty in the developing world. The EDCTP strongly believes that ultimately the outcome of this initiative and others will depend on the ownership and commitment to this vision by the partners, and by having the concerned countries play a central role.

Adapted interventions are essential to reduce the burden caused by these diseases. Current approaches to vaccine development suffer from common problems and shortcomings, which are shared by all of these diseases. The EDCTP believes that a common, coordinated approach will benefit and expedite developments in general (i.e. capacities and methodologies).

There are today insufficient capacities and overall capabilities to test products clinically in high-burden countries. The EDCTP upholds high scientific and ethic
'"/>

Contact: Sandor Vrij
vry@edctp.org
31-70-344-0885
Netherlands Organization for Scientific Research
11-Jun-2004


Page: 1 2

Related medicine news :

1. Media invitation first annual EDCTP Forum
2. South African MRC hosts the African branch office of EDCTP Secretariat
3. Americans support most uses of reproductive genetic testing, report on US attitudes reveals
4. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
5. Emergency department study supports giving dehydrated children fluids by mouth
6. Early supported discharge services can reduce long term dependency for stroke patients
7. Care of rural stroke patients improves with telephone support
8. Review supports link between HRT and stroke
9. Chamomile tea: New evidence supports health benefits
10. Psychological support helps adolescents with chronic fatigue syndrome
11. Social supports lessen effects of maltreatment on children vulnerable to depression

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: EDCTP welcomes support for HIV AIDS vaccine development

(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... center, is helping to bring awareness to International Overdose Awareness Day. The goal ... pause to recognize the warning signs so that they may get help. ...
(Date:9/2/2015)... ... September 02, 2015 , ... Please join the world ... , which was established by the Foundation in 2007 with the help of ... fund more research remains our top priority,” commented Christine Buckley, Executive Director of ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... of Breast Cancer Awareness Month (BCAM), Bright Pink, a national non-profit focused on ... will launch Act On Facts, a campaign to educate women to be breast ...
(Date:9/1/2015)... ... September 01, 2015 , ... An August 25 ... of plastic surgeries conducted each year on teenagers, quoting a New York City-area ... Beverly Hills-based plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly to ...
(Date:9/1/2015)... ... September 01, 2015 , ... The ... the treatment of androgenic alopecia in adults, announces Miami-based medical device manufacturer, Capillus, ... while also demonstrating its safety when used at home to combat hair loss. ...
Breaking Medicine News(10 mins):Health News:August 31 is International Overdose Awareness Day – Lakeview Health to Help Bring Awareness 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2
(Date:9/1/2015)... Sept. 1, 2015 Konica Minolta Medical Imaging ... (CR) system, designed to deliver enterprise level imaging to ... same Control Station as the Konica Minolta AeroDR wireless ... upgrade path from CR to DR. The SIGMA II ... improve workflow with unparalleled reliability and high capacity to ...
(Date:9/1/2015)... Sept. 1, 2015 Sleep Specialists, LLC ... and HGE Health Care Solutions, a leader in ... a comprehensive sleep management and cost reduction program ... OSA is a chronic medical condition characterized ... may increase a patient,s risk for cardiovascular disease, ...
(Date:9/1/2015)... Conn. , Sept. 1, 2015  Results from ... AD™ study demonstrate that 5g of idarucizumab enabled ... situations involving patients treated with dabigatran (Pradaxa ® ... of the anticoagulant effect of dabigatran enabled patients ... a median time of 1.7 hours between administration ...
Breaking Medicine Technology:Konica Minolta Launches New CR System with Low-Cost Upgrade Path to DR 2Sleep Specialists, LLC and HGE Health Care Solutions Announce Comprehensive Sleep Program 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 3New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 4New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 6New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 7New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 8New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 9
Cached News: